Journey Medical Corp
Journey Medical Corp (DERM): 10 pipeline candidates · 4 upcoming catalysts · ~11 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
11.4 months
D/E 1.97
Lead: Approved
10 candidates
4 upcoming, next in ~1566d
N/A
A transparent, data-derived signal for Journey Medical Corpacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$169.8M
Cash
$27.2M
Quarterly Burn
$10.1M
Runway
11.4 mo
Revenue
$16.0M
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (10 candidates)
Upcoming Catalysts (4)
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Loss of exclusivity — patent/exclusivity expiry opens the door to generic or biosimilar competition that can erode revenue.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
68
Total value held
$51.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 2,164,160 | $10.1M |
| wasatch advisors lp | 2,133,370 | $10.0M |
| tang capital management llc | 1,610,000 | $7.6M |
| blackrock, inc. | 972,862 | $4.6M |
| j. goldman & co lp | 500,188 | $2.3M |
| geode capital management, llc | 463,202 | $2.2M |
| millennium management llc | 383,067 | $1.8M |
| summit financial, llc | 379,807 | $1.8M |
| ikarian capital, llc | 251,436 | $1.2M |
| renaissance technologies llc | 242,500 | $1.1M |
Showing top 10 of 68 institutional holders of Journey Medical Corp. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Journey Medical Corp's pipeline?
Journey Medical Corp (DERM) has 10 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Journey Medical Corp's lead drug candidate?
Journey Medical Corp's most advanced tracked candidate is Accutane (Approved) for Severe recalcitrant nodular acne.
What is Journey Medical Corp's next catalyst?
Journey Medical Corp's next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: ZILXI" — expected October 1, 2030.
What is Journey Medical Corp's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Journey Medical Corp has approximately 11.4 months of cash runway.
What is Journey Medical Corp's market capitalization?
Journey Medical Corp's market capitalization is approximately $169.8M.
Get the full picture on Journey Medical Corp
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.